Background: Smoking is a major modifiable risk factor for Alzheimer's disease and other dementias (ADODs), but comprehensive assessments of its global burden remain scarce. Objective: This study examines spatiotemporal trends in smoking-attributable ADODs across 204 countries and territories from 1990 to 2021. Methods: Using data from the Global Burden of Disease (GBD) 2021 study, we estimated smoking-attributable mortality, disability-adjusted life years (DALYs), age-standardized mortality rate (ASMR), and age-standardized DALY rate (ASDR). Temporal trends were quantified via estimated annual percentage change (EAPC), and future trajectories were projected using autoregressive integrated moving average (ARIMA) models. Results: Between 1990 and 2021, global smoking-attributable ADOD deaths and DALYs increased by 108.85% (67,176 deaths) and 92.88% (1.53 million DALYs), respectively. However, age-standardized rates declined significantly: ASMR decreased by 22.22% (EAPC = −0.95, 95% CI: −0.99, −0.91) and ASDR by 21.30% (EAPC = −0.88, 95% CI: −0.92, −0.83). Men exhibited higher baseline rates, but women experienced steeper declines (ASMR EAPC: −1.60vs−0.79). Elderly populations disproportionately bore the highest burden, especially those ≥65 years. The middle-SDI region bore the heaviest burden (47,038,000 DALYs), while East Asia accounted for 38% of deaths. Projections suggest that the burden of smoking-related ADOD may continue to rise by 2036. Conclusions: The burden of smoking-related ADODs remains high, with marked disparities across age, gender and socioeconomic strata. Targeted interventions, such as tobacco taxation, smoking bans, and integrated cognitive screening programs.